A study to use hematological and biochemical parameters as a key in the diagnosis of acute mesenteric ischemia
Abstract
Aim: Acute mesenteric ischemia is still fatal in 59-92% of cases. Delay in diagnosis of acute mesenteric ischemia can cause dramatic increase in morbidity and mortality rates. However several diagnostic and disease related factors have been widely studied. Controversy still remains. In this study, we evaluated hematological and biochemical parameters in patients with acute mesenteric ischemia.
Methods: 46 patients (study group) who underwent emergent surgery for acute mesenteric ischemia and 46 patients (control group) operated for acute abdomen with another etiology other than acute mesenteric ischemia and internalized to intensive care unit were included in this study. Medical records and clinical data of acute mesenteric ischemia patients between January 2008 and December 2014 were evaluated with regard to 8 parameters; age, amylase, white blood cell count, mean platelet volume, creatine kinase, lactate dehydrogenase, lactate and D-dimer. These parameters were selected for their increased levels in acute mesenteric ischemia patients according to many published medical studies. Control group was formed randomly from patients followed in intensive care unit for their co-morbidities after acute abdomen operation in the same period. Gender was included in the table but was not taken into account as a parameter for the study.
Results: Mean values of age, white blood cell count, creatine kinase, lactate dehydrogenase, lactate and D-dimer were significantly higher in acute mesenteric ischemia group than the control group. Mean platelet volume was significantly lower in acute mesenteric ischemia group. The p values were for age (p=0.009), for amylase (0.475), for white blood cell (p=0.001) for mean platelet volume (0=0.001), for creatinine kinase (p=0.017), for lactate dehydrogenase (p=0.001), for lactate (p=0.001), for D-dimer (p=0.001) respectively.
Conclusion: White blood cell count, creatine kinase, lactate dehydrogenase, lactate and D-dimer levels increase; mean platelet volume decrease in acute mesenteric ischemia patients significantly.
Keywords
References
- 1. Paladino NC, Inviati A, Di Paola V, Busuito G, Amodio E, Bonventre S, et al. Predictive factors of mortality in patients with acute mesenteric ischemia. Ann Ital Chir. 2014;85:265-70.
- 2. Karabulut K, Gul M, Dundar ZD, Cander B, Kurban S, Toy H. Diagnostic and prognostic values of procalcitonin and phosphorus in acute mesenteric ischemia. Ulus Travma Cerrahi Derg. 2011;17:193-8.
- 3. Hamzaoglu I, Ulualp K, Balkan T, Cander B, Kurban S, Toy H. Abdominal emergencies in octogenerians. Ulus Travma Acil Cerrahi Derg. 2000;6:36-8.
- 4. Demir IE, Ceyhan GO, Friess H. Beyond lactate: Is there a role for serum lactate measurement in diagnosing acute mesenteric ischemia? Dig Surg. 2012;29:226-35.
- 5. Turkoglu A, Gul M, Oguz A, Bozdağ Z, Ülger BV, Yılmaz A, et al. Mean platelet volume: Is it a predictive parameter in diagnosis of acute mesenteric ischemia? Int Surg. 2015;100:962-5.
- 6. Aktimur R, Cetinkunar S, Yildirim K, Aktimur SH, Ugurlucan M, Ozlem N. Neutrophil-to-lymphocyte ratio as a diagnostic biomarker for the diagnosis of acute mesenteric ischemia. Euro J Trauma Emerg Surg. 2016;42:363-8.
- 7. Kisaoglu A, Bayramoglu A, Ozogul B, Atac K, Emet M, Atamanalp SS. Sensitivity and specificity of red cell distribution width in diagnosing acute mesenteric ischemia in patients with abdominal pain. World J Surg. 2014;38:2770-6.
- 8. Tanrikulu Y, Tanrikulu CS, Sabuncuoglu MZ, , Temiz A, Köktürk F, Yalçın B. Diagnostic utility of the neutrophil-lymphocyte ratio in patients with acute mesenteric ischemiaia retrospective cohort study. Ulus Travma Acil Cerrahi Derg. 2016;22:344-9.
Details
Primary Language
English
Subjects
Surgery
Journal Section
Research Article
Authors
Mikail Çakır
*
This is me
Türkiye
Doğan Yıldırım
This is me
Türkiye
Ahmet Kocakuşak
Türkiye
Okan Murat Aktürk
Türkiye
Leyla Zeynep Tigrel
This is me
Türkiye
Publication Date
July 20, 2018
Submission Date
April 11, 2018
Acceptance Date
July 5, 2018
Published in Issue
Year 2018 Volume: 3 Number: 2
Cited By
FAR Ratio as Prognostic Biomarker in AMI
SN Comprehensive Clinical Medicine
https://doi.org/10.1007/s42399-023-01451-x